Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

Dr. Remy Geenen

By using mint Lesion™, we are able to generate standardized, complete and consistent oncologic reports. Not only can we describe all the important aspects of a particular tumor, but we are also storing important data in the background, which can be used for quality control and science.

Related Resources

Related Resources

Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

University Hospital Munich (LMU): Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

A recent study[1] conducted by researchers at the University Hospital Munich (LMU) investigated the role of tumor growth rate (TGR) in predicting the…

RANZCR Brisbane 2023

10/19 to 10/21/2023 BRISBANE, AUSTRALIA

73rd Annual Scientific Meeting

A picture of a person looking at a brain scan and the interface of mint Lesion™ on a computer

Advancing Neuro-Oncology Assessments: Mint Medical to Integrate Newly Published RANO 2.0 Criteria into mint Lesion™

Glioblastomas and other gliomas are the most common malignant primary brain tumor types, yet few effective therapies are available. Clinical research…